Acquire patients. Grow service lines. Build brand.
Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer.
This evidence-based assessment estimates users’ current risks and high-grade risks of prostate cancer. The calculations take lifestyle, genetics and personal health histories into consideration, and is updated regularly.
Benefits for Patients
- Help consumers estimate their need for cancer screening, based on well-respected research and established algorithms.
- Empower users to explore their risk factors, and understand what they can or can’t do about them.
- Enable them to conveniently seek treatment at the right point of care for their situation AND your facilities’ resources.
Who’s Using Our HRAs?
View a summary of demographics & results of the Prostate Cancer Risk Assessments that our various clients ran throughout 2021.
Thank you for your interest.